Stocktoria
Fulgent Genetics, Inc. FLGT
Fulgent Genetics, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $322.7M | $283.5M | $289.2M | $619.0M | $992.6M | $421.7M | $32.5M | $21.4M | $18.7M | $18.3M |
| Gross profit | $130.9M | $107.2M | $104.5M | $366.9M | $777.1M | $331.9M | $18.4M | $10.7M | $10.2M | $11.6M |
| R&D expense | $53.9M | $48.8M | $41.4M | $28.9M | $24.2M | $11.6M | $6.5M | $5.5M | $4.2M | $3.6M |
| Operating income | -$91.1M | -$73.9M | -$195.5M | $178.5M | $676.0M | $290.2M | -$428,000 | -$5.1M | -$3.5M | $918,000 |
| Interest expense | — | — | — | $346,000 | $117,000 | $20,000 | — | — | — | — |
| Income tax | -$8.4M | -$8.1M | $1.2M | $42.1M | $174.8M | $72.5M | $43,000 | $36,000 | -$1.0M | $920,000 |
| Net income | -$60.5M | -$42.7M | -$167.8M | $143.4M | $507.4M | $214.3M | -$411,000 | -$5.6M | -$2.5M | -$5.3M |
| Operating cash flow | -$101.6M | $21.1M | $27.0M | $253.5M | $538.6M | $140.6M | $5.5M | -$675,000 | $1.3M | $4.4M |
| Free cash flow | -$124.2M | -$19.3M | $4.8M | $234.7M | $514.8M | $105.5M | $4.3M | -$3.0M | -$1.6M | $648,000 |
| Cash & equivalents | $50.2M | $55.1M | $97.5M | $79.5M | $164.9M | $87.4M | $12.0M | $6.7M | $6.5M | $7.9M |
| Total assets | $1.2B | $1.2B | $1.2B | $1.4B | $1.3B | $700.5M | $88.8M | $53.9M | $57.2M | $58.0M |
| Total liabilities | $106.8M | $90.8M | $102.0M | $116.2M | $112.8M | $131.1M | $6.0M | $2.8M | $3.0M | $3.6M |
| Shareholders' equity | $1.1B | $1.1B | $1.1B | $1.3B | $1.2B | $569.4M | $82.8M | $51.2M | $54.2M | $54.5M |
Growth · year-over-year · Revenue CAGR 37.6%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +13.8% | -2.0% | -53.3% | -37.6% | +135.4% | +1196.5% | +52.3% | +14.0% | +2.5% | +90.9% |
| Net income growth | — | — | -217.0% | -71.7% | +136.7% | — | — | — | — | — |
| Free cash flow growth | — | -501.5% | -98.0% | -54.4% | +387.9% | +2333.6% | — | — | -341.4% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.